USNA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
223.3M
-10.8%
250.2M
+10.6%
226.2M
+5.9%
213.7M
-9.4%
235.8M
Cost of Revenue
48.3M
-18.7%
59.4M
+20.3%
49.4M
+1.2%
48.8M
-2.7%
50.2M
Gross Profit
174.9M
-8.3%
190.8M
+7.9%
176.8M
+7.2%
164.9M
-11.2%
185.7M
Operating Expenses
165.8M
-6.3%
176.9M
+2.3%
173.0M
+5.7%
163.6M
-3.1%
168.9M
R&D
0
0
0
0
0
SG&A
82.3M
-6.7%
88.3M
+13.0%
78.1M
-9.2%
85.9M
+4.9%
81.9M
Operating Income
9.1M
-34.1%
13.9M
+263.3%
3.8M
+212.0%
1.2M
-92.7%
16.7M
EBITDA
16.8M
-24.1%
22.2M
-14.2%
25.8M
+183.2%
9.1M
-62.7%
24.5M
Net Income
-27951000
-501.7%
7.0M
+536.3%
-1595000
+76.1%
-6662000
-163.8%
10.4M
EPS (Basic)
$-1.16
-382.9%
$0.41
+510.0%
$-0.10
+72.2%
$-0.36
-169.2%
$0.52
EPS (Diluted)
$-1.16
-382.9%
$0.41
+510.0%
$-0.10
+72.2%
$-0.36
-169.2%
$0.52
Shares (Diluted)
18.5M
+0.4%
18.4M
+0.2%
18.4M
+0.5%
18.3M
-1.3%
18.5M
USANA Health Sciences (USNA) โ€” Financials